PortfoliosLab logoPortfoliosLab logo
DRN vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DRN vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Real Estate Bull 3x Shares (DRN) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DRN achieves a 19.36% return, which is significantly higher than CURE's -20.11% return. Over the past 10 years, DRN has underperformed CURE with an annualized return of -5.10%, while CURE has yielded a comparatively higher 11.41% annualized return.


DRN

1D
1.30%
1M
-6.56%
YTD
19.36%
6M
16.51%
1Y
6.60%
3Y*
7.32%
5Y*
-11.56%
10Y*
-5.10%

CURE

1D
-2.92%
1M
1.15%
YTD
-20.11%
6M
-19.30%
1Y
19.67%
3Y*
-0.86%
5Y*
-0.04%
10Y*
11.41%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DRN vs. CURE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DRN
Direxion Daily Real Estate Bull 3x Shares
19.36%-11.24%-5.29%12.03%-67.26%152.94%-55.37%81.86%-25.11%7.50%
CURE
Direxion Daily Healthcare Bull 3x Shares
-20.11%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%

Correlation

The correlation between DRN and CURE is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (3Y)
Calculated over the trailing 3-year period

0.52

Correlation (5Y)
Calculated over the trailing 5-year period

0.59

Correlation (10Y)
Calculated over the trailing 10-year period

0.50

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.51

The correlation between DRN and CURE shifts across timeframes, from 0.43 (1 year) to 0.59 (5 years), reflecting how their relationship changes across market environments.

DRN vs. CURE - Sectors Allocation Comparison


Sectors
DRN
CURE

Real Estate

19.6%

-

Basic Materials

0.4%

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Healthcare

-

100.0%

Industrials

-

-

Technology

-

-

Utilities

-

-

Real Estate

DRN
19.6%
CURE

-

Basic Materials

DRN
0.4%
CURE

-

Communication Services

DRN

-

CURE

-

Consumer Cyclical

DRN

-

CURE

-

Consumer Defensive

DRN

-

CURE

-

Energy

DRN

-

CURE

-

Financial Services

DRN

-

CURE

-

Healthcare

DRN

-

CURE
100.0%

Industrials

DRN

-

CURE

-

Technology

DRN

-

CURE

-

Utilities

DRN

-

CURE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DRN vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DRN
DRN Risk / Return Rank: 1212
Overall Rank
DRN Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
DRN Sortino Ratio Rank: 1212
Sortino Ratio Rank
DRN Omega Ratio Rank: 1212
Omega Ratio Rank
DRN Calmar Ratio Rank: 1212
Calmar Ratio Rank
DRN Martin Ratio Rank: 1212
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 1717
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1616
Calmar Ratio Rank
CURE Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRN vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Real Estate Bull 3x Shares (DRN) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DRNCUREDifference

Sharpe ratio

Return per unit of total volatility

0.17

0.46

-0.29

Sortino ratio

Return per unit of downside risk

0.50

0.98

-0.48

Omega ratio

Gain probability vs. loss probability

1.06

1.11

-0.05

Calmar ratio

Return relative to maximum drawdown

0.29

0.64

-0.35

Martin ratio

Return relative to average drawdown

0.65

1.49

-0.84

DRN vs. CURE - Sharpe Ratio Comparison

The current DRN Sharpe Ratio is 0.17, which is lower than the CURE Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of DRN and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DRNCUREDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.17

0.46

-0.29

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.20

-0.00

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.08

0.23

-0.32

Sharpe Ratio (All Time)

Calculated using the full available price history

0.21

0.46

-0.25

Drawdowns

DRN vs. CURE - Drawdown Comparison

The maximum DRN drawdown since its inception was -86.32%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for DRN and CURE.


Loading charts...

Drawdown Indicators


DRNCUREDifference

Max Drawdown

Largest peak-to-trough decline

-86.32%

-69.19%

-17.13%

Max Drawdown (1Y)

Largest decline over 1 year

-24.28%

-31.10%

+6.82%

Max Drawdown (3Y)

Largest decline over 3 years

-48.26%

-51.93%

+3.67%

Max Drawdown (5Y)

Largest decline over 5 years

-80.58%

-52.23%

-28.35%

Max Drawdown (10Y)

Largest decline over 10 years

-86.32%

-69.19%

-17.13%

Current Drawdown

Current decline from peak

-65.97%

-36.59%

-29.38%

Average Drawdown

Average peak-to-trough decline

-35.06%

-18.14%

-16.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.89%

13.34%

-2.45%

Volatility

DRN vs. CURE - Volatility Comparison

The current volatility for Direxion Daily Real Estate Bull 3x Shares (DRN) is 11.21%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 11.87%. This indicates that DRN experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DRNCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.21%

11.87%

-0.66%

Volatility (6M)

Calculated over the trailing 6-month period

29.18%

30.02%

-0.84%

Volatility (1Y)

Calculated over the trailing 1-year period

40.04%

43.14%

-3.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

56.66%

43.68%

+12.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.62%

49.51%

+11.11%

DRN vs. CURE - Expense Ratio Comparison

DRN has a 0.99% expense ratio, which is lower than CURE's 1.08% expense ratio.


Dividends

DRN vs. CURE - Dividend Comparison

DRN's dividend yield for the trailing twelve months is around 2.23%, more than CURE's 1.34% yield.


PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
1.34%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
DRN
Direxion Daily Real Estate Bull 3x Shares
2.23%2.81%2.24%2.84%2.70%4.21%1.90%2.59%3.11%0.91%

Frequently Asked Questions


DRN and CURE have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CURE has higher volatility (11.87%) compared to DRN (11.21%). In terms of maximum drawdown, DRN dropped -86.32% vs CURE's -69.19%.

On 10-year performance, CURE leads with 11.41% vs -5.10% for DRN. On fees, DRN is cheaper at 0.99% per year. On volatility, DRN has been the lower-risk option at 11.21%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 11.41% return vs -5.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

DRN is cheaper with a 0.99% expense ratio, compared with 1.08% for CURE.

DRN has the higher dividend yield at 2.23%, compared with 1.34% for CURE.

DRN is categorized as REIT, while CURE is Leveraged Equities. DRN tracks MSCI US REIT Index (300%), while CURE tracks Health Care Select Sector Index (300%). Their fees differ too: 0.99% for DRN and 1.08% for CURE.

CURE currently has the higher Sharpe Ratio (0.46 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DRN and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer